Label concept combines first-opening indication, blinding for clinical trials
Schreiner MediPharm’s new Flexi-Cap for Clinical Trial Supplies provides anti-counterfeit protection with blinding for transparent containers.
Archives for June 18, 2017
Nevada law requires insulin firms to disclose prices and profits
Drug manufacturers selling insulin in Nevada in the US must disclose what they charge and how much the make from the drug under legislation signed into law last week.
CDMO KBI Biopharma acquires Alliance Protein Laboratories
KBI Biopharma, Inc. (KBI) is acquiring the San Diego-based contract research organization (CRO) Alliance Protein Laboratories.
Adamis has not set US price for newly approved rival to Mylan's $600 EpiPen
The US FDA has approved Symjepi, a rival to Mylan’s emergency anaphylaxis treatment EpiPen made by Adamis Pharmaceuticals Corporation.
A change of focus: B-MS sells Irish API plant to Korean SK Biotek
Bristol-Myers Squibb (B-MS) has announced it will sell its Swords, Ireland-based API manufacturing facility as part of its focus on biologics.
Pfizer recalls injectables made at Rocky Mount over potential contamination risk
Pfizer has recalled four injectables – including the already scarce heart surgery drug Sodium Bicarbonate - made at Hospira's facility in Rocky Mount, North Carolina after identifying a potential contamination risk.
CiToxLAB and KaLy-Cell join to address drug development threat, hepatotoxicity
KaLy-Cell has partnered with CiToxLAB to evaluate hepatotoxicity and perform metabolism studies during drug development.
Researchers define action profile of Bial compound
New insight into BIA 10-2474 clinical trial shines light on preclinical testing
Experts are calling for an increased focus on human cellular model development after animal tests failed to detect the toxicity of an experimental drug before the first-in-human clinical trial that left one dead.